Mironid
Targeted therapeutic innovation to improve health and quality of life
Mironid has raised €46M across 2 funding rounds from 7 investors, most recently a Series B round in Aug 2026. Based in Newhouse, UK; founded 2015; active in Healthtech. Data as of 28 Oct 2026.
Total raised
€46M
€45,898,630
Funding rounds
2
Investors
7
distinct backers
Active since
2016-06
latest 2026-08
Funding by year
EUR raised per year · 2026 YTDMironid — funding by year — interactive chart.
Data table
| Mironid — funding by year | |
|---|---|
| 2016 | €6.0M |
| 2026 | €40M |
Signals
High confidenceRaise-next likelihood27
base rate 48% for Series B
- ▼ Raised very recently
- ▲ Up-round momentum
- ▼ Low backer re-investment
Exit likelihood18
base rate 11% (2+ rounds)
- ▲ €30M+ raised
- ▲ 11y since founding (typical exit age)
- ▲ Recently backed by strong-exit-track investors
Timing: too soon vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2026-08-07 | Series B | €40M | BioGeneration Ventures,Epidarex Capital,Roche Venture Fund,Scottish National Investment Bank,Sofinnova Partners,University of Strathclyde | View deal → |
| 2016-06-01 | Series A | €6.0M | Epidarex Capital,Scottish Investment Bank - Scottish Enterprise | View deal → |